MWNA
TECX

Marshall Wace North America’s Tectonic Therapeutic TECX Stock Holding History

Marshall Wace North America’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,054
Closed -$2.25M – 1537
2020
Q1 		$2.25M Sell
12,054
-4,037
-25% -$951K 0.02% 458
2019
Q4 		$3.89M Buy
+16,091
New +$3.1M 0.02% 434
2019
Q1 		– Sell
-42
Closed -$8K – 1963
2018
Q4 		$8K Buy
+42
New +$12.8K ﹤0.01% 1433
2018
Q3 		– Sell
-2,397
Closed -$821K – 1426
2018
Q2 		$821K Buy
+2,397
New +$865K ﹤0.01% 983

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Marshall Wace North America's TECX Position: Q2 2020 in Review

Marshall Wace North America sold out of Tectonic Therapeutic (TECX) in Q2 2020, closing a stake of 12,054 shares — an estimated $2.25M sold.

Marshall Wace North America first reported a position in TECX in Q2 2018 and held it in 4 quarters. The position peaked at $3.89M in Q4 2019. 98 funds tracked by Wall St. Rank hold TECX as of Q2 2020.

  • Marshall Wace North America reported no remaining Tectonic Therapeutic position as of Q2 2020 after selling out during the quarter.
  • Marshall Wace North America sold 12,054 Tectonic Therapeutic shares in Q2 2020, an estimated $2.25M.
  • Marshall Wace North America first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 4 quarters.
  • Marshall Wace North America's Tectonic Therapeutic position peaked at $3.89M in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2020.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.